跳至主要内容
临床试验/NCT05428358
NCT05428358招募中不适用

Incremental Value of Magnetic Resonance Imaging in Selection of Pancreatic Cancer Patients for Surgery (MAGIPAC): A Randomized Clinical Trial.

University of Aarhus5 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2022年8月30日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
200
试验地点
5
主要终点
Change in treatment strategy

研究概览

简要总结

The aim of the study is to examine the incremental value of using magnetic resonance imaging (MRI) in addition to computed tomography (CT) in the diagnostic workup of pancreatic cancer patients.

详细描述

The aim of the study is to examine the incremental value of using magnetic resonance imaging (MRI) in addition to computed tomography (CT) in the diagnostic workup of pancreatic cancer patients. We will conduct a nationwide, prospective clinical trial to examine the incremental value of using MRI for identification of liver metastases in pancreatic cancer patients.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 99 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Change in treatment strategy

时间窗: 1 week

Change in treatment strategy from intended curative resection to other treatment based on MRI scan

次要结局

  • Surgery(1 month)
  • Intraoperatively detected liver metastases(1 month)
  • Liver metastases(1 week)
  • Overall survival (1-year)(1 year)
  • Resection(1 month)
  • Overall survival (3-year)(3 years)
  • Recurrence-free survival(3 years)
  • Healthcare costs(3 years)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (5)

Loading locations...

相似试验

Incremental Value of Magnetic Resonance Imaging in... | 临床试验